Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease.
暂无分享,去创建一个
[1] W. Britt,et al. Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression. , 1991, Journal of immunology.
[2] P. Greenberg. Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. , 1991, Advances in immunology.
[3] H. Kodo,et al. [Cytomegalovirus pneumonia after bone marrow transplantation]. , 1990, Nihon rinsho. Japanese journal of clinical medicine.
[4] J. Meyers,et al. Cytomegalovirus infection after autologous bone marrow transplantation: occurrence of cytomegalovirus disease and effect on engraftment. , 1990, Blood.
[5] S. Riddell,et al. The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells. , 1990, Journal of immunological methods.
[6] K. Atkinson,et al. Reconstruction of the haemopoietic and immune systems after marrow transplantation. , 1990, Bone marrow transplantation.
[7] B. Dörken,et al. T-cell ontogeny after autologous bone marrow transplantation: failure to synthesize interleukin-2 (IL-2) and lack of CD2- and CD3-mediated proliferation by both CD4- and CD8+ cells even in the presence of exogeneous IL-2. , 1989, Blood.
[8] M. Martelli,et al. Lymphokine production by T-cell clones after human bone marrow transplantation. , 1989, Blood.
[9] G. Heller,et al. Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. , 1989, Blood.
[10] H. Deeg,et al. Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial. , 1989, Blood.
[11] A. Nademanee,et al. Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients. , 1988, Transplantation.
[12] E. Reed,et al. Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. , 1988, Annals of internal medicine.
[13] J. Sissons,et al. Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses , 1988, The Journal of experimental medicine.
[14] H. Deeg,et al. Serum cyclosporine concentration and risk of acute graft-versus-host disease after allogeneic marrow transplantation. , 1988, The New England journal of medicine.
[15] S. Spector,et al. Generation of human cytomegalovirus-specific cytotoxic T-lymphocytes in a short-term culture. , 1988, Journal of immunological methods.
[16] S. Jonjić,et al. A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection , 1988, Journal of virology.
[17] U. Koszinowski,et al. Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host , 1988, The Journal of experimental medicine.
[18] J. Sissons,et al. Human cytomegalovirus‐specific cytotoxic T cells: their precursor frequency and stage specificity , 1988, European journal of immunology.
[19] M. Thornquist,et al. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. , 1988, The New England journal of medicine.
[20] K. Okuno,et al. Requirements for T cell recognition and elimination of retrovirally-transformed cells. , 1988, Princess Takamatsu symposia.
[21] U. Koszinowski,et al. CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity , 1987, Journal of virology.
[22] M. Oldstone,et al. Recent clinical isolates of cytomegalovirus suppress human cytomegalovirus-specific human leukocyte antigen-restricted cytotoxic T-lymphocyte activity , 1986, Journal of virology.
[23] G. Trinchieri,et al. Requirement for HLA-DR+ accessory cells in natural killing of cytomegalovirus-infected fibroblasts , 1986, The Journal of experimental medicine.
[24] R. Miller,et al. Long-lasting deficit of functional T cell precursors in human bone marrow transplant recipients revealed by limiting dilution methods. , 1986, Journal of immunology.
[25] N. Flournoy,et al. Risk factors for cytomegalovirus infection after human marrow transplantation. , 1986, The Journal of infectious diseases.
[26] J. Sissons,et al. Cytomegalovirus - its cellular immunology and biology. , 1986, Immunology today.
[27] A. Rimm,et al. Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. , 1986, Annals of internal medicine.
[28] D. Johnston,et al. Immune recovery following allogeneic bone marrow transplantation. , 1985, Transplantation.
[29] S. Jonjić,et al. Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs , 1985, Journal of virology.
[30] R. Storb,et al. Cellular interactions in marrow-grafted patients. III. Normal interleukin 1 and defective interleukin 2 production in short-term patients and in those with chronic graft-versus-host disease. , 1985, Transplantation.
[31] H. Deeg,et al. RECOVERY OF IN VIVO CELLULAR IMMUNITY AFTER HUMAN MARROW GRAFTING: Influence of Time Postgrafting and Acute Graft‐Versus‐Host Disease , 1984, Transplantation.
[32] J. Biggs,et al. Human bone marrow allograft recipients: production of, and responsiveness to, interleukin 2. , 1983, Journal of immunology.
[33] R. Storb,et al. Allogeneic Bone‐Marrow Transplantation , 1983, Immunological reviews.
[34] R. Storb,et al. Cellular interactions in marrow-grafted patients. I. Impairment of cell-mediated lympholysis associated with graft-vs-host disease and the effect of interleukin 2. , 1983, Journal of immunology.
[35] L. Borysiewicz,et al. Human cytomegalovirus‐specific cytotoxic T lymphocytes: requirements for in vitro generation and specificity , 1983, European journal of immunology.
[36] J. Manischewitz,et al. Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. , 1982, The New England journal of medicine.
[37] P. Parham,et al. Monomorphic anti-HLA-A,B,C monoclonal antibodies detecting molecular subunits and combinatorial determinants. , 1982, Journal of immunology.
[38] J. Manischewitz,et al. HLA-restricted cytotoxic T lymphocyte and nonthymic cytotoxic lymphocyte responses to cytomegalovirus infection of bone marrow transplant recipients. , 1981, Journal of immunology.
[39] N. Flournoy,et al. Cytomegalovirus infection and specific cell-mediated immunity after marrow transplant. , 1980, The Journal of infectious diseases.
[40] J. Waner,et al. Blastogenic response of human lymphocytes to human cytomegalovirus. , 1977, Clinical and experimental immunology.
[41] R Storb,et al. Bone-marrow transplantation (first of two parts). , 1975, The New England journal of medicine.